Ghazal Basirinia, holds an MSc in Genetics and is pursuing a PhD in cancer research, focusing on nanoparticle-based cancer therapy and targeted drug delivery systems.

Her research interests include cancer biology, nanomedicine, and nanotechnology, with an emphasis on developing innovative nanomaterials for precise and personalized therapeutic applications.